A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
Clinical trial NCT02415400 · COMPLETED
Trial details
- NCT number
- NCT02415400
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-04
- Primary completion
- 2018-11-10
- Enrollment
- 4614
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.